EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
How Cloud Computing and AI Revolutionize Pharmaceutical Supply Chain Management
The pharma supply chain management has been considered as one of the most complicated spheres of operations in any industry As opposed to the traditional supply chain pharmaceutical supply chains have to juggle patient safety regulatory compliance cold chain integrity global sourcing and unpredictable demand and cost pressures simultaneously
Innovative Pricing Models in the EU: Making Medicines Affordable for All
Pricing policies are important determinants in delivering sufficiently cheap medicines in all the member nations of the EU High costs of meeting the required medical care together with arising independent differentiated technological improvements have rendered exhausted pricing structures as uncompetitive tools for fairness New mechanisms of pricing have been introduced
Unveiling the Revolutionary Potential: Exploring Blockchain Technology in Pharma
The pharmaceutical industry is renowned for its stringent regulations complex supply chains and crucial emphasis on data integrity In recent years the emergence of blockchain technology has sparked considerable interest
Advancing Pharmacovigilance Talent for AI: Overcoming Skills and Resource Barriers
In the transforming field of pharmacovigilance PV artificial intelligence AI is reshaping how drug safety is monitored and managed As PV evolves from manual reactive workflows to sophisticated AIaugmented systems the imperative for comprehensive workforce upskilling grows stronger Organisations and professionals must adapt to new technical demands regulatory requirements and ethical challenges to...
Gene Therapy: Breakthrough Treatments for Rare Diseases
The idea of gene therapy is radically changing the sphere of medicine with the possibilities to cure the patients with the rare hereditary diseases These diseases which are usually brought about by the alteration of the sequence
COVID-19 Vaccines & SARS-CoV-2 Variants: Who is winning the Race?
It was not uncommon to name the year as annus horribilis as the SARSCoV quickly spread all over the globe causing the first pandemic in years leading to devastating consequences on health economy and the society in general Neither drugs nor vaccines were available for more or less the whole first year of the pandemic causing devastation helplessness and uncertainty Since the beginning of the COV...
-
Techno Trends
University of Queensland Researchers Unlock New Drug Target for Neurodegenerative Disease Therapies
University of Queensland UQ researchers have developed a novel drug molecule that targets the hardtostudy immune receptor CaR opening new possibilities for treatments targeting neurodegenerative diseases such as Motor Neurone Disease MND
-
Projects
Evonik Announces US$100 Million Modernization of U.S. Drug Substance CDMO Facility
Evonik has announced a US million investment to modernize its Tippecanoe Labs manufacturing site in Lafayette Indiana over the next five years The investment is aimed at strengthening the companys US drug substance
-
Research Insights
A genomic-led strategy to anticipate drug safety effects
Safetyrelated issues account for approximately of failures in new drug discovery programs On top of that many are discovered during postmarketing surveillance
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Innovative Pricing Models in the EU: Making Medicines Affordable for All
Debi Jones
In this article, we discuss new approaches to drug pricing in the EU: value based pricing, risk sharing, subscription and differential pricing. These strategies are to achieve cost reduction for medic...
-
2
Unveiling the Revolutionary Potential: Exploring Blockchain Technology in Pharma
Sarah Richards
This article explores the transformative potential of blockchain technology in the pharmaceutical industry, addressing challenges such as counterfeit drugs, supply chain inefficiencies, and data manag...
-
3
Advancing Pharmacovigilance Talent for AI: Overcoming Skills and Resource Barriers
John Praveen
In the evolving world of pharmacovigilance, artificial intelligence revolutionises drug safety by automating data processing, enhancing signal detection, and enabling real-time risk prediction. Succes...
-
4
Gene Therapy: Breakthrough Treatments for Rare Diseases
Kate Williamson
As a novel healing technique, gene therapy targets core issues in hereditary diseases. This is another approach where damaged genes are altered or removed; this has a ray of hope in diseases like SCID...
-
5
COVID-19 Vaccines & SARS-CoV-2 Variants: Who is winning the Race?
Kenneth Lundstrom
Although COVID-19 vaccines have proven efficient and safe, the continuous emergence of novel SARS-CoV-2 mutants, properly called variants of concern, has resulted in a race between vaccine efficacy an...
press releases Read more...
FairJourney Bio Delivers Antibody Engineering for Novel Tumor-Conditional IL-12 Therapeutic Approach That Unlocks the Potential of Localized Cytokine Activation
FairJourney Bio FJBio a global antibody discovery expert today announced the publication of a peerreviewed study in mAbs describing a novel approach with the potential to improve the therapeutic window of IL
Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
Ipsen announced today it has completed the acquisition of Kartos Therapeutics a clinicalstage biopharmaceutical company adding latestage MDM inhibitor navtemadlin in Phase III clinical development in myelofibrosis
Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases
At the SSIEM Annual Symposium in Helsinki Galen Ltd and POA Pharma announced the launch of Galsana a new global brand for their metabolic product portfolio bringing together established products
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026
Infex Therapeutics a leading antiinfectives specialist today announced that new Phase IIa study data for RESPX INFEX its firstinclass antivirulence monoclonal antibody therapy in development for NCFB patients
Events Read more...
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
LATEST NEWS Read more...
Lupin and Tenpoint Therapeutics partner to commercialise YUVEZZI™ across European markets
Lupin Limited has announced that its wholly owned subsidiary VISUfarma BV has entered into an exclusive licensing agreement with Visus Therapeutics Inc a wholly owned subsidiary of Tenpoint Therapeutics Holding Limited
Rein Therapeutics receives US FDA Fast Track designation for LTI-03 in idiopathic pulmonary fibrosis
Rein Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for LTI an investigational treatment being developed for idiopathic pulmonary fibrosis IPF
IDEAYA Biosciences Announces Clinical Collaboration with Genentech for MTAP-Deleted, KRAS G12D-Mutant Pancreatic Cancer
IDEAYA Biosciences Inc NASDAQ IDYA has entered into a clinical collaboration with Genentech a member of the Roche Group to evaluate IDE in combination with GDC RG in patients
NTx Bio Supports Baylor College of Medicine in Manufacturing Personalised Cancer Vaccine for Phase 1 Melanoma Trial
NTx Bio is supporting Baylor College of Medicine in the manufacturing of a personalised cancer vaccine being evaluated in Diakonos Oncologys Phase trial for patients with refractory melanoma
VectorBuilder and Lir Therapeutics partner to advance AAV capsids for clinical development
VectorBuilder and Lir Therapeutics have entered into a strategic collaboration to develop adenoassociated virus AAV capsids that combine strong biological performance with the manufacturing and scalability requirements needed for clinical development
Cytovance Biologics launches standalone analytical services for biologics development
Cytovance Biologics has expanded its analytical services portfolio to provide standalone analytical support for biotechnology and pharmaceutical companies The new offering gives clients access to Cytovances analytical expertise and regulatoryready solutions without requiring a manufacturing engageme...









